Mathew Birdsall Abrams, PhD, is director of science and training at the International Neuroinformatics Coordinating Facility (INCF), a global organization dedicated to open, FAIR, and citable neuroscience. Abrams is a neuroscientist with over 25 years of experience in both experimental neuroscience and clinical psychiatry, as well as 12 years of experience in community coordination, community building, and product development in neuroinformatics. He conducted his doctoral thesis research at Tulane University and Karolinska Institutet, obtained his MPH in health systems management at Tulane University School of Public Health and Tropical Medicine, and completed his undergraduate education at the University of Richmond.

Derek L. Buhl, PhD, is the scientific director of AbbVie. With over a decade of experience in the industry, Buhl is responsible for the translational strategy for CNS disorders in late-stage discovery and across clinical development stages, first-in-human, proof-of-mechanism, proof-of-concept, registration studies as well as life cycle management studies. He earned his bachelor’s degrees in psychology and a PhD in neuroscience from Rutgers University-Newark.